Business Description
ASP Isotopes Inc
NAICS : 325180
SIC : 2899
ISIN : US00218A1051
Total Employee Number:
271Compare
Compare
Traded in other countries / regions
ASPI.USAISO.South AfricaW62.Germany Index Membership
Russell 2000Russell 3000 IPO Date
2022-11-10Description
ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Currently, the company has three operating segments: (i) nuclear fuels, (ii) specialist isotopes and related services, and (iii) construction services. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.95 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 1.02 | |||||
Debt-to-EBITDA | -2.12 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.26 | |||||
Beneish M-Score | 3.06 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -117.1 | |||||
3-Year EPS without NRI Growth Rate | -129.7 | |||||
3-Year FCF Growth Rate | -27.3 | |||||
3-Year Book Growth Rate | 88.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 23.11 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 125.84 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 42.38 | |||||
9-Day RSI | 42.97 | |||||
14-Day RSI | 42.36 | |||||
3-1 Month Momentum % | -44.16 | |||||
6-1 Month Momentum % | -31.63 | |||||
12-1 Month Momentum % | -63.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.87 | |||||
Quick Ratio | 3.85 | |||||
Cash Ratio | 3.63 | |||||
Days Inventory | 18.57 | |||||
Days Sales Outstanding | 97.94 | |||||
Days Payable | 70.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -46 | |||||
Shareholder Yield % | -26.75 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 18.32 | |||||
Operating Margin % | -312.3 | |||||
Net Margin % | -427.98 | |||||
EBITDA Margin % | -412.9 | |||||
FCF Margin % | -270.88 | |||||
OCF Margin % | -219.76 | |||||
ROE % | -77.03 | |||||
ROA % | -32.69 | |||||
ROIC % | -47.95 | |||||
3-Year ROIIC % | -37.43 | |||||
ROC (Joel Greenblatt) % | -113.01 | |||||
ROCE % | -36.69 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 56.41 | |||||
PS Ratio | 13.51 | |||||
PB Ratio | 1.94 | |||||
Price-to-Tangible-Book | 1.99 | |||||
EV-to-EBIT | -4.74 | |||||
EV-to-EBITDA | -4.94 | |||||
EV-to-Forward-EBITDA | 1275.67 | |||||
EV-to-Revenue | 20.4 | |||||
EV-to-Forward-Revenue | 19.3 | |||||
EV-to-FCF | -7.53 | |||||
Price-to-GF-Value | 0.17 | |||||
Earnings Yield (Greenblatt) % | -21.1 | |||||
FCF Yield % | -13.82 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ASPI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ASP Isotopes Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 30.853 | ||
| EPS (TTM) ($) | -1.32 | ||
| Beta | 3.3484 | ||
| 3-Year Sharpe Ratio | 0.78 | ||
| 3-Year Sortino Ratio | 1.93 | ||
| Volatility % | 86.19 | ||
| 14-Day RSI | 42.36 | ||
| 14-Day ATR ($) | 0.297542 | ||
| 20-Day SMA ($) | 4.11025 | ||
| 12-1 Month Momentum % | -63.04 | ||
| 52-Week Range ($) | 3.51 - 14.49 | ||
| Shares Outstanding (Mil) | 153.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ASP Isotopes Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ASP Isotopes Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-12-18 10:00 | In 114 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-20 08:30 | In 86 days | ||
| Third quarter earnings results for 2026 | 2026-11-20 | In 85 days | ||
| Capital Markets Day | 2026-09-08 10:00 | In 13 days | ||
| 95th Emerging Growth Conference | 2026-08-20 10:15 | 4.09 (+4.07%) | ||
| Second quarter earnings results for 2026 | 2026-08-14 | 4.28 (-0.23%) | ||
| Canaccord Genuity\'s 46th Annual Growth Conference | 2026-08-12 08:00 | 4.32 (-0.62%) | ||
| First quarter earnings results for 2026 | 2026-05-20 | 4.84 (-5.84%) | ||
| business update conference call | 2026-04-13 08:00 | 4.48 (+4.67%) | ||
| Annual report for 2025 | 2026-04-10 | 4.21 (-3.88%) |
Show
Entries
ASP Isotopes Inc Frequently Asked Questions
What is ASP Isotopes Inc(ASPI)'s stock price today?
The current price of ASPI is $3.95. The 52 week high of ASPI is $14.49 and 52 week low is $3.51.
When is next earnings date of ASP Isotopes Inc(ASPI)?
The next earnings date of ASP Isotopes Inc(ASPI) is 2026-11-20 Est..
Does ASP Isotopes Inc(ASPI) pay dividends? If so, how much?
ASP Isotopes Inc(ASPI) does not pay dividend.
Guru Commentaries on NAS:ASPI
Rogue Funds
Bullish
2025 Q1
What the manager wrote
ASP Isotopes has begun full production for all three of their plants, and the stock price has re-rated positively in response. The expected sales of Silicon-28 and Ytterbium will drive real revenue into the company, likely leading to a serious catalyst in the stock price. A TerraPower deal is anticipated before Q2 ends, which, combined with revenue realization, will exert extreme upwards pressure on the stock price. ASP Isotopes' ability to enrich HALEU positions it as the only viable option for the next half decade, indicating significant upside potential.
Press Release
Articles on ASP Isotopes Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers